1-5 of 5
Darren W. Davis
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract C18: Epithelial and mesenchymal phenotypic characterization and mutation detection in circulating tumor cells isolated from peripheral blood of non-small cell lung cancer patients with ApoStream® technology

Priya Balasubramanian, Vishal Gupta, David Hasegawa, Carmen Y. Lam, Ran An, Swetha Pratyusha Gunturu, Hai T. Tran, John V. Heymach, Darren W. Davis
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2015) 14 (12_Supplement_2): C18.
https://doi.org/10.1158/1535-7163.TARG-15-C18
Published: 01 December 2015
View article titled, Abstract C18: Epithelial and mesenchymal phenotypic characterization and mutation detection in circulating tumor cells isolated from peripheral blood of non-small cell lung cancer patients with ApoStream® technology
Journal Articles

Abstract B51: ApoStream™ isolated circulating tumor cells from primary breast cancer patients reveals heterogeneous phenotypes related to epithelial-mesenchymal transition and stem cell markers.

Kenna L. Anderes, Insiya Jafferji, Vladislava O. Melnikova, Jackson A. Summer, Darren W. Davis, James M. Reuben, Naoto T. Ueno
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2013) 12 (11_Supplement): B51.
https://doi.org/10.1158/1535-7163.TARG-13-B51
Published: 01 November 2013
View article titled, Abstract B51: ApoStream™ isolated circulating tumor cells from primary breast cancer patients reveals heterogeneous phenotypes related to epithelial-mesenchymal transition and stem cell markers.
Journal Articles

Abstract C29: Characterization and identification of specific EGFR mutations in circulating tumor cells (CTCs) isolated from non-small cell lung cancer patients using an antibody independent method, ApoStream™: An update report.

Hai T. Tran, Vladislava Melnikova, Anne S. Tsao, Frank V. Fossella, Faye M. Johnson, Vali Papadimitrakoupoulou, Katherine Richardson, Marcia E. Lewis, Ben Legendre, Kenna L. Anderes, Darren W. Davis, John V. Heymach
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2013) 12 (11_Supplement): C29.
https://doi.org/10.1158/1535-7163.TARG-13-C29
Published: 01 November 2013
View article titled, Abstract C29: Characterization and identification of specific EGFR mutations in circulating tumor cells (CTCs) isolated from non-small cell lung cancer patients using an antibody independent method, ApoStream™: An update report.
Journal Articles

Abstract C16: Prospective real‐time analysis of p‐cadherin expression to select patients into a phase I oncology trial

Darren W. Davis, Wen Liu, Iman Jilani, Yujian Zhang, John W. Barlow, Louise M. Miller, Reba Winstanley, Jayesh Desai, Kathy R. Alpaugh, Harry Cooper, Roger B. Cohen, Yung‐Jue Bang, Do‐Youn Oh, Mi‐Yeong Kim, Yoon‐Ju Bae, Athena Countouriotis, David R. Shalinsky, Woo Ho Kim
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (12_Supplement): C16.
https://doi.org/10.1158/1535-7163.TARG-09-C16
Published: 10 December 2009
View article titled, Abstract C16: Prospective real‐time analysis of p‐cadherin expression to select patients into a phase I oncology trial
Journal Articles

The proteasome inhibitor bortezomib synergizes with gemcitabine to block the growth of human 253JB-V bladder tumors in vivo

Ashish M. Kamat, Takashi Karashima, Darren W. Davis, Laura Lashinger, Menashe Bar-Eli, Randall Millikan, Yu Shen, Colin P. N. Dinney, David J. McConkey
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2004) 3 (3): 279–290.
https://doi.org/10.1158/1535-7163.279.3.3
Published: 16 March 2004
View article titled, The proteasome inhibitor bortezomib synergizes with gemcitabine to block the growth of human 253JB-V bladder tumors <em>in vivo</em>
Open the PDF for The proteasome inhibitor bortezomib synergizes with gemcitabine to block the growth of human 253JB-V bladder tumors <em>in vivo</em> in another window